Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDunedin Ent.it. Regulatory News (DNE)

  • This share is currently suspended. It was suspended at a price of 470.00

Share Price Information for Dunedin Ent.it. (DNE)

Share Price is delayed by 15 minutes
Get Live Data
470.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: -
DNE Live PriceLast checked at - London Stock Exchange

Intraday Dunedin Ent.it. Share Chart

Interim Management Statement

16 May 2011 10:33

RNS Number : 6513G
Dunedin Enterprise Inv Trust PLC
16 May 2011
 

Dunedin Enterprise Investment Trust PLC (Company No SC52844) - Interim Management Statement

Dunedin Enterprise Investment Trust PLC ("Dunedin Enterprise") presents its Interim Management Statement for the quarter ended 31 March 2011. This is the Company's first interim management statement for the financial year to 31 December 2011, as required by the FSA Disclosure and Transparency Rule 4.3.

 

1. Investment Objective

 

Dunedin Enterprise specialises in the provision of private equity finance. Private equity is medium to long term finance provided in return for an equity stake in established, potentially high growth private companies. The Company's investment objective is to achieve substantial long term capital growth in its assets through capital gains from its investments.

 

2. Unaudited net asset value per share

 

The unaudited net asset value per share at 31 March 2011 was 509.2p. This represents an increase of 2.4% from the level at 31 December 2010.

 

3. Share price and discount

 

The share price rose by 3.7% from 300p to 311p in the quarter to 31 March 2011. This compares to a decrease in the FTSE Small Cap Index of 0.1% over the same period.

 

Based upon the net asset value per share of 509.2p, the discount of the share price to the net asset value per share has remained largely unchanged moving from 39.7% to 38.9% in the quarter. When cash is excluded from net assets then the discount increases to 50.1%.

 

The share price at the close of business on 13 May 2011 was 355p, which was 14.1% higher than at 31 March 2011. The share price of 355p represents a discount of 30.3% to the net asset value per share of 509.2p and when cash is excluded from net assets then the discount increases to 39.0%.

 

4. Balance Sheet

 

The balance sheet as at 31 March 2011 is noted below:-

 

 
£'m
Investments:-
 
Dunedin managed
86.7
Third party managed
15.1
Listed private equity
16.1
Legacy technology funds
1.8
 
119.7
Cash and near cash
34.3
Other assets/liabilities 
(0.3)
Total net assets
153.7
 
 
Net asset value per share (p)
509.2

  

5. Valuations

 

The portfolio of investments has been revalued at 31 March 2011. The increase in net asset value in the quarter can be attributed to:-

 

·; an increase in the value of European fund investments of £2.4m due to a combination at the portfolio company level of strong trading, de-gearing and a movement from cost to an earnings based valuation,

·; an increase in the value of the SWIP Private Equity Fund of Funds II PLC of £1.8m due to an increase in underlying fund values,

·; a reduction of £0.3m following the sale of the European listed investments, and

·; other movements of -£0.3m.

 

6. Commitments

 

As at 31 March 2011 the Company has outstanding capital commitments to limited partnership funds of £77.4m. In addition to cash and near cash balances of £34.3m at 31 March 2011 the Company has a listed private equity investment (SWIP) of £16.1m.

 

7. Outlook

 

The number of new business opportunities is encouraging, but the market remains very competitive.

 

 

For further information on Dunedin Enterprise please go to www.dunedin.com

 

ENDS

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGCGDUBXBBGBL
Date   Source Headline
29th Jan 20251:17 pmRNSStatement re First Distribution in Liquidation
6th Jan 20252:48 pmRNSResult of General Meeting
30th Dec 20245:30 pmRNSDunedin Enterprise Investment Trust
19th Dec 20243:38 pmRNSGM - Announcement of Suspension Timetable
19th Dec 20243:27 pmRNSGM - Announcement of Suspension Timetable
9th Dec 20247:00 amRNSHolding(s) in Company
4th Dec 202410:00 amRNSGeneral Meeting re: Member's Voluntary Liquidation
4th Dec 202410:00 amRNSPublication of Circular and Winding-up Timetable
3rd Dec 20248:44 amRNSGeneral Meeting re: Member's Voluntary Liquidation
29th Nov 20241:38 pmRNSPortfolio Update
1st Nov 20247:00 amRNSPreliminary Unaudited Net Asset Value at 30/09/24
11th Sep 20247:00 amRNSHalf-year Report
27th Aug 20247:00 amRNSDividend Declaration
5th Aug 20247:00 amRNSPortfolio Update
1st Aug 20247:00 amRNSPreliminary unaudited net asset value at 30/6/24
15th May 20241:17 pmRNS1st Quarter Results
15th May 20241:12 pmRNSResult of AGM
7th May 20245:37 pmRNSHolding(s) in Company
1st May 20247:00 amRNSPreliminary Unaudited Net Asset Value at 31/3/24
22nd Mar 20247:00 amRNSAnnual Financial Report
5th Feb 20241:58 pmRNSHolding(s) in Company
5th Feb 20241:56 pmRNSHolding(s) in Company
5th Feb 20241:54 pmRNSHolding(s) in Company
1st Feb 20247:00 amRNSPreliminary Unaudited Net Asset Value at 31/12/23
19th Dec 20232:34 pmRNSHolding(s) in Company
19th Dec 20232:22 pmRNSHolding(s) in Company
13th Dec 20237:00 amRNSDividend Declaration
21st Nov 20237:00 amRNSPremier Hytemp realisation & potential winding-up
16th Nov 20237:00 amRNS3rd Quarter Results
6th Nov 20234:33 pmRNSHolding(s) in Company
3rd Nov 20237:05 amRNSPortfolio Update
1st Nov 20237:00 amRNSPreliminary Unaudited Net Asset Value at 30/9/23
28th Sep 20237:00 amRNSPortfolio Update
15th Sep 20237:00 amRNSHalf-year Report
1st Aug 20237:00 amRNSPreliminary unaudited net asset value at 30/6/23
6th Jun 20239:01 amRNSHolding(s) in Company
22nd May 202310:05 amRNSHolding(s) in Company
10th May 20232:42 pmRNSResult of AGM
10th May 20232:42 pmRNS1st Quarter Results
2nd May 20237:00 amRNSPreliminary unaudited net asset value at 31/3/23
24th Mar 20237:00 amRNSAnnual Financial Report
1st Feb 20237:00 amRNSPreliminary Unaudited Net Asset Value at 31/12/22
7th Dec 20221:02 pmRNSDirector/PDMR Shareholding
7th Dec 20221:00 pmRNSDirector/PDMR Shareholding
7th Dec 20221:00 pmRNSDirector/PDMR Shareholding
6th Dec 202211:12 amRNSDirector/PDMR Shareholding
6th Dec 202211:09 amRNSDirector/PDMR Shareholding
1st Dec 202212:42 pmRNSHolding(s) in Company
30th Nov 20225:50 pmRNSDirector/PDMR Shareholding
30th Nov 20225:48 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.